NCT04460625

Brief Summary

The research was planned to determine the effect of different blood groups on the 90-day survival of intensive care patients who were treated and maintained for the first time in the intensive care unit. The research is a retrospective descriptive research. For the first time in an intensive care unit aged 18 and over, between January 1, 2014 and December 31, 2019, of a state and a university hospital in the Western Black Sea Region, in intensive care units (both medical and surgical patients), All the patients, who were hospitalized in the intensive care unit for at least 24 hours, were discharged from the intensive care unit for 90 days and less, and all the information in the Patient Information Form can be accessed from the automation system. The research will be conducted between 01.04.2020-01.07.2020 by collecting the necessary data within the 'Patient Information Form' of the patients from the information processing unit of the hospitals where the research will be conducted.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,114

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 1, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 7, 2020

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 5, 2022

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 7, 2022

Completed
Last Updated

February 8, 2022

Status Verified

February 1, 2022

Enrollment Period

1.8 years

First QC Date

July 1, 2020

Last Update Submit

February 7, 2022

Conditions

Keywords

intensive careintensive care nursingcritical patientblood groupsurvival

Outcome Measures

Primary Outcomes (2)

  • Examination of the correlation between blood group of patients and rh factor and secondary complication development during admission to intensive care units

    At the onset of critical illness,knowing all possible risk factors to effectively manage patients creates a chance to achieve more successful treatment and care outcomes.Although it is more difficult time consuming and costly to determine the effect of genetic diversity on survival,the addition of ABO blood groups to the risk classification system according to the effect on survival may also provide additional benefits to the patient as it will be easier,faster and inexpensive.It is observed that this factor is missing in the mortality risk diagnosis forms used during the intensive care hospitalization currently used.Patients with 0 blood group,in which the AB blood group plays a role in both venous thromboembolism and coronary artery disease as a risk factor and their tendency to clot;It has been reported that the bleeding rate increases significantly,especially in surgical procedures with high risk of blood loss.If it is considered that the procedures applied in intensive care ünit.

    Whether or not complications develop within 90 days of admission to patients in intensive care unit

  • Examining the correlation between the patient's blood group and rh factor and mortality in patients

    The relationship between patients' blood groups and mortality is thought to exist as a result of research. In a research; After the patients were admitted to the intensive care unit, the relationship between blood groups and mortality was evaluated in the 90-day period; It has been determined that patients with intensive care with AB blood group have a higher 90-day survival time compared to other blood group patients. In line with this result, there is a need for studies for the risk assessment scales and the addition of the blood group factor for intensive care patients.

    Mortality rates will be checked within 90 days from the patients' admission to intensive care unit.

Secondary Outcomes (1)

  • Examination of the correlation between patients 'invasive mechanical ventilation status and duration, and patients' 90-day survival

    90 days

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Zonguldak Atatürk State Hospital located in the Western Black Sea Region, were treated between January 1, 2014 and 31.12.2019 in intensive care units (both medical and surgical patients). The number of patients admitted to the intensive care units was determined from the information processing unit of the hospitals and determined as 4.120. These patients will form the universe of the research. Of these patients; All patients who are hospitalized for the first time in the intensive care unit, who are in the intensive care unit for at least 24 hours, who are discharged from the intensive care unit for 90 days and less, all information in the data collection form, 18 years of age and over, will be the sample group.

You may qualify if:

  • Being 18 or older
  • Being in the intensive care unit for the first time,
  • To stay in the intensive care unit for at least 24 hours.
  • Being discharged from the intensive care unit in 90 days and less
  • All information in the Patient Information Form can be accessed from the automation system.

You may not qualify if:

  • Being under the age of 18
  • Having previously slept in the intensive care unit
  • Intensive care hospitalization has ended in less than 24 hours.
  • Staying in the intensive care unit for more than 90 days
  • Failure to reach all questions in the Patient Information form from the automation system

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zonguldak Atatürk State Hospital

Zonguldak, Meşrutiyet, 67100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Critical Illness

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Sibel Köstekli

    Zonguldak Bülent Ecevit University Faculty of Health Sciences Nursing Department

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Zonguldak Bülent Ecevit University Faculty of Health Sciences

Study Record Dates

First Submitted

July 1, 2020

First Posted

July 7, 2020

Study Start

May 1, 2020

Primary Completion

February 5, 2022

Study Completion

February 7, 2022

Last Updated

February 8, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations